These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7804735)

  • 41. Role of Factor XII in hemostasis and thrombosis: clinical implications.
    Renné T; Gailani D
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein disulfide-isomerase - a trigger of tissue factor-dependent thrombosis.
    Kiouptsi K; Reinhardt C
    Clin Hemorheol Microcirc; 2016; 64(3):279-286. PubMed ID: 28128754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro.
    Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ
    Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The blood coagulation cascade.
    Schenone M; Furie BC; Furie B
    Curr Opin Hematol; 2004 Jul; 11(4):272-7. PubMed ID: 15314527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The advisability of modifying the current outline of blood coagulation].
    Barkagan ZS; Kuznik BI
    Ter Arkh; 1990; 62(7):81-6. PubMed ID: 2251671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polystyrene nanoparticles affecting blood coagulation.
    Oslakovic C; Cedervall T; Linse S; Dahlbäck B
    Nanomedicine; 2012 Aug; 8(6):981-6. PubMed ID: 22197724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A guide for diagnosis of patients with arterial and venous thrombosis.
    Quinn C; Hill J; Hassouna H
    Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiology of blood coagulation.
    Bloom AL
    Haemostasis; 1990; 20 Suppl 1():14-29. PubMed ID: 2083865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel targets for anticoagulants lacking bleeding risk.
    Bickmann JK; Baglin T; Meijers JCM; Renné T
    Curr Opin Hematol; 2017 Sep; 24(5):419-426. PubMed ID: 28731874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.
    Wygrecka M; Jablonska E; Guenther A; Preissner KT; Markart P
    Thromb Haemost; 2008 Mar; 99(3):494-501. PubMed ID: 18327397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The thrombophilic state in cancer patients.
    Gouin-Thibault I; Achkar A; Samama MM
    Acta Haematol; 2001; 106(1-2):33-42. PubMed ID: 11549775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
    Bertina RM
    Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assays for thrombosis factors: relations to plasma lipids.
    Tracy RP
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1669S-1673S. PubMed ID: 9129508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices.
    Adatya S; Sunny R; Fitzpatrick MJ; Colvin M; Thennapan T; John R; Dodge Zantek N; Pritzker M; Eckman P; Uriel N
    J Heart Lung Transplant; 2016 Nov; 35(11):1311-1320. PubMed ID: 27836023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New models of hemostasis.
    McMichael M
    Top Companion Anim Med; 2012 May; 27(2):40-5. PubMed ID: 23031454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypercoagulability.
    Hirsh J
    Semin Hematol; 1977 Oct; 14(4):409-25. PubMed ID: 72416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.